CardioGenics Holdings Valuation
| CGNH Stock | USD 0.0001 0.00 0.00% |
CardioGenics Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CardioGenics Holdings from analyzing the firm fundamentals such as Return On Asset of -1.15, price to earning of (0.67) X, and Shares Outstanding of 96.05 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CardioGenics Holdings' price fluctuation is very steady at this time. Calculation of the real value of CardioGenics Holdings is based on 3 months time horizon. Increasing CardioGenics Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CardioGenics Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CardioGenics Pink Sheet. However, CardioGenics Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of CardioGenics Holdings' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CardioGenics Holdings' stock price.
Estimating the potential upside or downside of CardioGenics Holdings helps investors to forecast how CardioGenics pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CardioGenics Holdings more accurately as focusing exclusively on CardioGenics Holdings' fundamentals will not take into account other important factors: CardioGenics Holdings Total Value Analysis
CardioGenics Holdings is currently estimated to have valuation of 2.3 M with market capitalization of 1.92 M, debt of 0, and cash on hands of 96.81 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CardioGenics Holdings fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.3 M | 1.92 M | 0 | 96.81 K |
CardioGenics Holdings Asset Utilization
One of the ways to look at asset utilization of CardioGenics is to check how much profit was generated for every dollar of assets it reports. CardioGenics Holdings shows a negative utilization of assets of -1.15 percent, losing $0.0115 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of CardioGenics Holdings shows how discouraging it operates for each dollar spent on its assets.CardioGenics Holdings Ownership Allocation
CardioGenics Holdings holds a total of 96.05 Million outstanding shares. Almost 97.49 percent of CardioGenics Holdings outstanding shares are held by general public with 2.52 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CardioGenics Holdings Profitability Analysis
Net Loss for the year was (1.92 M) with profit before overhead, payroll, taxes, and interest of 0.About CardioGenics Holdings Valuation
An absolute valuation paradigm, as applied to CardioGenics Pink Sheet, attempts to find the value of CardioGenics Holdings based on its fundamental and basic technical indicators. By analyzing CardioGenics Holdings's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of CardioGenics Holdings's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of CardioGenics Holdings. We calculate exposure to CardioGenics Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CardioGenics Holdings's related companies.CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Mississauga, Canada. Cardiogenics Holdings operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct CardioGenics Holdings' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CardioGenics Holdings' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CardioGenics Holdings' valuation analysis, follow these 8 steps:- Gather financial information: Obtain CardioGenics Holdings' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CardioGenics Holdings' revenue streams: Identify CardioGenics Holdings' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CardioGenics Holdings' industry and market trends, including the size of the market, growth rate, and competition.
- Establish CardioGenics Holdings' growth potential: Evaluate CardioGenics Holdings' management, business model, and growth potential.
- Determine CardioGenics Holdings' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CardioGenics Holdings' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CardioGenics Holdings Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -49.6 M |
Complementary Tools for CardioGenics Pink Sheet analysis
When running CardioGenics Holdings' price analysis, check to measure CardioGenics Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioGenics Holdings is operating at the current time. Most of CardioGenics Holdings' value examination focuses on studying past and present price action to predict the probability of CardioGenics Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioGenics Holdings' price. Additionally, you may evaluate how the addition of CardioGenics Holdings to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |